Publication: Schedules and survival of rituximab in patients with anti-neutrophil cytoplasmic antibody associated vasculitis: a multi-center, real-world experience
| dc.contributor.coauthor | Deniz, R. | |
| dc.contributor.coauthor | Dagli, P. Akyuz | |
| dc.contributor.coauthor | Isik, A. | |
| dc.contributor.coauthor | Ocak, T. | |
| dc.contributor.coauthor | Uludogan, B. C. | |
| dc.contributor.coauthor | Ugur, K. | |
| dc.contributor.coauthor | Erdir, B. | |
| dc.contributor.coauthor | Asicioglu, E. | |
| dc.contributor.coauthor | Pehlivan, Y. | |
| dc.contributor.coauthor | Bilge, N. S. Yasar | |
| dc.contributor.coauthor | Kasifoglu, T. | |
| dc.contributor.coauthor | Direskeneli, H. | |
| dc.contributor.coauthor | Alibaz-Oner, F. | |
| dc.contributor.coauthor | Erten, S. | |
| dc.contributor.coauthor | Omma, A. | |
| dc.contributor.coauthor | Bes, C. | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.kuauthor | Kanıtez, Nilüfer Alpay | |
| dc.contributor.kuauthor | Enlice, Mehmet Ali | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.date.accessioned | 2025-09-10T04:58:22Z | |
| dc.date.available | 2025-09-09 | |
| dc.date.issued | 2025 | |
| dc.description.fulltext | No | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | WOS | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.volume | 83 | |
| dc.identifier.doi | 10.1136/annrheumdis-2025-eular.B859 | |
| dc.identifier.eissn | 1468-2060 | |
| dc.identifier.embargo | No | |
| dc.identifier.issn | 0003-4967 | |
| dc.identifier.quartile | Q1 | |
| dc.identifier.uri | https://doi.org/10.1136/annrheumdis-2025-eular.B859 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/30325 | |
| dc.identifier.wos | 001530421100042 | |
| dc.keywords | Glucocorticoids | |
| dc.keywords | Infection | |
| dc.keywords | Autoantibodies | |
| dc.keywords | Renal system | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | Annals of the Rheumatic Diseases | |
| dc.subject | Rheumatology | |
| dc.title | Schedules and survival of rituximab in patients with anti-neutrophil cytoplasmic antibody associated vasculitis: a multi-center, real-world experience | |
| dc.type | Meeting Abstract | |
| dspace.entity.type | Publication | |
| person.familyName | Kanıtez | |
| person.familyName | Enlice | |
| person.givenName | Nilüfer Alpay | |
| person.givenName | Mehmet Ali | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |
